U.S. flag

An official website of the United States government

NIH: National Institute of Diabetes and Digestive and Kidney Diseases NIH: National Institute of Diabetes and Digestive and Kidney Diseases 75 years: 1950-2025 75 years: 1950-2025
  1. Home
  2. About NIDDK
  3. Staff Directory
  4. Daniel Gossett, Ph.D.
Go to Staff Directory home

Daniel Gossett, Ph.D.

Photo of Danny Gossett
Program Director: Division of Kidney, Urologic, & Hematologic Diseases
NIDDK Small Business Programs, Translational Research, and Technology Development

Responsibilities & Activities

As a Program Director in the Division of Kidney, Urologic, and Hematologic Diseases, my portfolio includes biomedical imaging of the kidney, technology development, and translational research in the areas of kidney, urologic, and hematologic diseases, as well as the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.

I am the Small Business Program Manager for the NIDDK, and my SBIR/STTR portfolio includes device, diagnostic, and other technology development in in the areas of kidney, urologic, and hematologic diseases.

I am the Program Officer for the NIDDK (Re)Building a Kidney Consortium, which is working to improve or restore failing kidney function after injury or disease by either (1) stimulating productive kidney repair/regeneration in vivo, or (2) generating functional kidney tissue ex vivo for transplantation.

I am a Project Scientist for the NIDDK Kidney Precision Medicine Project (KPMP), which aims to ethically obtain and evaluate human kidney biopsies from participants with Acute Kidney Injury (AKI) or Chronic Kidney Disease (CKD), create a kidney tissue atlas, define disease subgroups, and identify critical cells, pathways, and targets for novel therapies.

My other professional activities include participating in several NIDDK and NIH working groups (see below).

Research Programs

Kidney Bioengineering, Biotechnology, & Imaging
The development of new technologies for the diagnosis, monitoring, or treatment of kidney diseases.

Urology Bioengineering, Biotechnology, & Imaging
The development of new technologies for the diagnosis, monitoring, or treatment of urologic diseases.

Committees & Working Groups

  • NIDDK Data Science Working Group, Member
  • NIDDK Small Business Working Group, Member
  • NIH Small Business Programs Managers Committee, Member
  • NIH Common Fund Stimulating Peripheral Activity to Relieve Conditions (SPARC) Working Group, Member
  • NIH Microphysiological Systems (MPS) Working Group, Member

Select Experience

Vice President Research and Development, Cytovale Inc., 2013-2014

Fellowship, University of California, Los Angeles, 2012-2013

Ph.D., University of California, Los Angeles, 2012

Last Reviewed March 2025